{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:21:34Z","timestamp":1759940494236,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Glob. Women\u2019s Health"],"abstract":"<jats:p>Although opioid use disorder (OUD) in pregnancy has increased significantly in the last years, there are still significant gaps in scientific data and in access to evidence-based treatments. OUD in pregnancy is associated with negative health outcomes in the pregnant person, the fetus, and the newborn. To prevent these consequences, it is imperative to identify OUD and provide treatment as soon as possible in the pregnancy. Effective treatments, such as medication for opioid use disorder (MOUD), are safe in pregnancy but not routinely prescribed. For Hispanic pregnant people, these evidence-based treatments are less likely to be prescribed, are less consistently used and are less likely to be continued during the first year postpartum. Increasing access to high quality evidence-based treatments for OUD in Hispanic pregnant people is a public health emergency. This article will offer an overview of the known health disparities of treating perinatal OUD in Hispanics and propose strategies to address these disparities.<\/jats:p>","DOI":"10.3389\/fgwh.2025.1575164","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:24:14Z","timestamp":1748496254000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Status and innovation needed to address health disparities in opioid use disorders among hispanic pregnant individuals"],"prefix":"10.3389","volume":"6","author":[{"given":"Karen G.","family":"Martinez-Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darlene I.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"volume-title":"Evidence- Based, Whole-Person Care Pregnant People who Have Opioid Use Disorder. Advisory. Publication No. PEP23-02-002","year":"2024","key":"B1"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4.","DOI":"10.58464\/2155-5834.1353","article-title":"Putting families first: how the opioid epidemic is affecting children and families, and the child welfare policy options to address it","volume":"9","author":"Waite","year":"2018","journal-title":"JARC"},{"key":"B3","doi-asserted-by":"publisher","first-page":"100206","DOI":"10.1016\/j.dadr.2023.100206","article-title":"Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort","volume":"9","author":"Wang","year":"2023","journal-title":"Drug Alcohol Depend Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.15585\/mmwr.mm6928a1","article-title":"Vital signs: prescription opioid pain reliever use during pregnancy- 34 US jurisdictions","volume":"69","author":"Ko","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1111\/add.15582","article-title":"Outcomes associated with the use of medications for opioid use disorder during pregnancy","volume":"116","author":"Krans","year":"2021","journal-title":"Addiction"},{"key":"B6","doi-asserted-by":"publisher","first-page":"489.e1","DOI":"10.1016\/j.ajog.2019.05.045","article-title":"Maternal drug-related death and suicide are leading causes of postpartum death in California","volume":"221","author":"Goldman-Mellor","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet Gynecol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/aje\/kwab132","article-title":"Ischemic placental disease, preterm delivery, and their association with opioid use during pregnancy","volume":"191","author":"Esposito","year":"2022","journal-title":"Am J Epidemiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/OGX.0000000000001094","article-title":"Opioid use in pregnancy: a review","volume":"78","author":"Ryan","year":"2023","journal-title":"Obstet Gynecol Surv"},{"key":"B11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jamapediatrics.2023.1047","article-title":"Maternal opioid use disorder and the risk of postneonatal infant mortality","volume":"177","author":"Grossarth","year":"2023","journal-title":"JAMA Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e2021050279","DOI":"10.1542\/peds.2021-050279","article-title":"Opioid use disorder and perinatal outcomes","volume":"148","author":"Piske","year":"2021","journal-title":"Pediatrics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10615-022-00847-x","article-title":"Unpacking perinatal experiences with opioid use disorder: relapse risk implications","volume":"51","author":"Rankin","year":"2023","journal-title":"Clin Soc Work J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/08897077.2021.1949664","article-title":"Disparities in receipt of medications for opioid use disorder among pregnant women","volume":"43","author":"Henkhaus","year":"2022","journal-title":"Subst Abus"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1007\/s11606-023-08306-0","article-title":"Racial and ethnic inequities in buprenorphine and methadone utilization among reproductive-age women with opioid use disorder: an analysis of multi-state medicaid claims in the USA","volume":"38","author":"Xu","year":"2023","journal-title":"J Gen Intern Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"109868","DOI":"10.1016\/j.drugalcdep.2023.109868","article-title":"Duration of medication for opioid use disorder during pregnancy and postpartum by race\/ethnicity: results from 6 state medicaid programs","volume":"247","author":"Austin","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"B17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s10995-023-03795-1","article-title":"They will never forget how you made them feel: implementing harm reduction in the perinatal setting","volume":"27","author":"Puccio","year":"2023","journal-title":"Matern. Child Health J"},{"volume-title":"Pregnancy and Substance Use: A Harm Reduction Toolkit","year":"2022","author":"Goyer","key":"B18"},{"key":"B19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ogc.2023.10.004","article-title":"Substance use in pregnancy and its impact on communities of color","volume":"51","author":"Habersham","year":"2024","journal-title":"Obstet Gynecol Clin North Am"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.acap.2023.01.012","article-title":"Disparities in maternal-infant drug testing, social work assessment, and custody at 5 hospitals","volume":"23","author":"Cohen","year":"2023","journal-title":"Acad Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"106798","DOI":"10.1016\/j.chiabu.2024.106798","article-title":"Instead of just taking my baby, they could\u2019ve actually given me a chance\u201d: experiences with plans of safe care among birth parents impacted by perinatal substance use","volume":"152","author":"He","year":"2024","journal-title":"Child Abuse Negl"},{"key":"B22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jogn.2024.04.006","article-title":"Intersecting substance use disorder and unmet social needs in rural pregnant women","volume":"53","author":"Allen","year":"2024","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee opinion No. 711: ppioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e205734","DOI":"10.1001\/jamanetworkopen.2020.5734","article-title":"Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts","volume":"3","author":"Schiff","year":"2020","journal-title":"JAMA Netw Open"},{"year":"","key":"B25","article-title":"US Census Bureau"},{"key":"B26","doi-asserted-by":"publisher","first-page":"S423","DOI":"10.2105\/AJPH.2024.307765","article-title":"The health of the hispanic\/latino population in the United States","volume":"114","author":"Borrell","year":"2024","journal-title":"Am J Public Health"},{"article-title":"Agency for Healthcare Research and Quality (AHRQ)","volume-title":"National Healthcare Quality and Disparities Report Chartbook on Health Care for Hispanics","year":"2015","key":"B27"},{"key":"B28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10488-006-0040-8","article-title":"Latino adults' access to mental health care: a review of epidemiological studies","volume":"33","author":"Cabassa","year":"2006","journal-title":"Adm Policy Ment Health"},{"key":"B29","doi-asserted-by":"crossref","first-page":"1013314","DOI":"10.3389\/fpsyt.2023.1013314","article-title":"Ataque de nervios: the impact of sociodemographic, health history, and psychological dimensions on Puerto Rican adults","volume":"14","author":"Roche-Miranda","year":"2023","journal-title":"Front Psychiatry"},{"key":"B30","first-page":"1","article-title":"Births: final data for 2021","volume":"72","author":"Osterman","year":"2023","journal-title":"Natl Vital Stat Rep"},{"key":"B31","first-page":"1","article-title":"Infant mortality in the United States, 2021: data from the period linked birth\/infant death file","volume-title":"Natl Vital Stat Rep","author":"Ely","year":"2023"},{"key":"B32","article-title":"NCHS Data Brief, no 486","volume-title":"Trends in cesarean delivery in Puerto Rico, 2018\u20132022","author":"Osterman","year":""},{"key":"B33","doi-asserted-by":"publisher","first-page":"S450","DOI":"10.2105\/AJPH.2024.307702","article-title":"Social justice is overdue for puerto rican mothers","volume":"114","author":"Lebron","year":"2024","journal-title":"Am J Public Health"},{"year":"2021","key":"B34"},{"volume-title":"Alertas los Expertos por el Abuso de los Opioides en Personas Mayores","year":"2018","author":"Marrero","key":"B35"},{"volume-title":"Pareja Encontrada Dentro de un Auto en Estacionamiento de Toa Baja Muri\u00f3 de Sobredosis","year":"2022","key":"B36"},{"volume-title":"Contin\u00faan los Env\u00edos de Naloxona Para Revertir los Efectos de Opioides a Los Centros de Salud de Puerto Rico","year":"2019","author":"Cooper","key":"B37"},{"volume-title":"Fideicomiso de Ciencias, Tecnolog\u00eda e Investigaci\u00f3n de Puerto Rico","year":"2020","author":"Ocasio","key":"B38"},{"year":"","key":"B39","article-title":"Noticel. Se cuadruplica la tasa de embarazadas adictas a opioides"},{"year":"2014","key":"B40","article-title":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s10995-023-03842-x","article-title":"Early insights into implementation of universal screening, brief intervention, and referral to treatment for perinatal substance use","volume":"27","author":"Reese","year":"2023","journal-title":"Matern Child Health J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/bdr2.1516","article-title":"Fetal alcohol spectrum disorder prevention program: sBIRT\u2019s role in averting fetal alcohol spectrum disorders","volume":"111","author":"Manriquez","year":"2019","journal-title":"Birth Defects Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s10995-020-02892-9","article-title":"Integrating screening, brief intervention and referral to treatment (SBIRT) for substance use into prenatal care","volume":"24","author":"Hostage","year":"2020","journal-title":"Matern Child Health J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/ADM.0000000000000150","article-title":"Adapting screening, brief intervention, and referral to treatment for alcohol and drugs to culturally diverse clinical populations","volume":"9","author":"Manuel","year":"2015","journal-title":"J Addict Med"},{"volume-title":"A Practical Guide to Intervention in Health and Social Services with Pregnant and Postpartum Addicts and Alcoholics: Theoretical Framework, Brief Screening Tool, key Interview Questions, and Strategies for Referral to Recovery Resources","year":"1990","author":"Ewing","key":"B45"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/add.14651","article-title":"Accuracy of five self-report screening instruments for substance use in pregnancy","volume":"114","author":"Ondersma","year":"2019","journal-title":"Addiction"},{"key":"B47","doi-asserted-by":"publisher","first-page":"106323","DOI":"10.1016\/j.addbeh.2020.106323","article-title":"A review of nonpharmacological adjunctive treatment for postpartum women with opioid use disorder","volume":"105","author":"Martinez","year":"2020","journal-title":"Addict Behav"},{"volume-title":"Motivational Interviewing: Helping People Change","year":"2013","author":"Miller","key":"B48"}],"container-title":["Frontiers in Global Women's Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2025.1575164\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:24:20Z","timestamp":1748496260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2025.1575164\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":48,"alternative-id":["10.3389\/fgwh.2025.1575164"],"URL":"https:\/\/doi.org\/10.3389\/fgwh.2025.1575164","relation":{},"ISSN":["2673-5059"],"issn-type":[{"type":"electronic","value":"2673-5059"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"article-number":"1575164"}}